Oxidative stress and cell cycle checkpoint function

Free Radical Biology and Medicine

Volumn 28, Issue 9, 2000, Pages 1387-1404

  Shackelford, Rodney E ^a   Kaufmann, William K ^b   Paules, Richard S ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cycle; Checkpoints; DNA damage; Free radicals; Oxidative stress; Reactive oxygen species

Indexed keywords

DNA; FREE RADICAL; REACTIVE OXYGEN METABOLITE;

ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CARCINOGENESIS; CELL CYCLE; DNA DAMAGE; HUMAN; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

EID: 0034190327     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00224-0     Document Type: Article

References (275)

1. Harman D.J. Aging a theory based on free radical and radiation chemistry . Gerontology. 11:1956;298-300.
2. Floyd R.A. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 4:1990;2587-2597.
3. Ames B.N., Shigenaga M.K. Oxidants are a major contributor to aging. Ann. N. Y. Acad. Sci. 663:1992;85-96.
4. Jenner P. Oxidative damage in neurodegenerative disease. Lancet. 344:1994;796-798.
5. Dandona P., Thusu K., Cook S., Snyder B., Makowski J., Armstrong D., Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet. 347:1996;444-445.
6. Mahadik S.P., Scheffer R.E. Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids. 55:1996;45-54.
7. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59:1979;527-605.
8. Nikjoo H., O'Neill P., Terrissol M., Goodhead D.T. Modelling of radiation-induced DNA damage the early physical and chemical event . Int. J. Radiat. Biol. 66:1994;453-457.
9. Skov K.A. The contribution of hydroxyl radical to radiosensitization a study of DNA damage . Radiat. Res. 99:1984;502-510.
10. Teoule R. Radiation-induced DNA damage and its repair. Int. J. Radiat. Biol. 51:1987;573-589.
11. Ward J.F. DNA damage produced by ionizing radiation in mammalian cells identities, mechanisms of formation, and reparability . Prog. Nucleic Acid Res. Mol. Biol. 35:1988;95-125.
12. Rotman G., Shiloh Y. Ataxia-telangiectasia is ATM a sensor of oxidative damage and stress? Bioessays. 19:1997;911-917.
13. Morrison B.M., Morrison J.H. Amyotrophic lateral sclerosis associated with mutations in superoxide dismutase a putative mechanism of degeneration . Brain Res. Brain Res. Rev. 29:1999;121-135.
14. Conger A.D., Fairchild L.M. Breakage of chromosomes by oxygen. Proc. Natl. Acad. Sci. USA. 38:1952;289-299.
15. Papa S., Skulachev V.P. Reactive oxygen species, mitochondria, apoptosis and aging. Mol. Cell. Biochem. 174:1997;305-319.
16. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. 1986;Oxford University Press, Oxford.
17. Boveris A., Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem. J. 134:1973;707-716.
18. Adams D.O., Hamilton T.A. Macrophages as destructive cells in host defense. Gallin J.I., Goldstein I.M., Synderman R., Inflammation basic principles and clinical correlates . 1992;637-662 Raven, New York.
19. Klebanoff S.J. Phagocytic cells products of oxygen metabolism . Gallin J.I., Goldstein I.M., Synderman R., Inflammation basic principles and clinical correlates . 1988;391-444 Raven, New York.
20. Shacter E., Beecham E.J., Covey J.M., Kohn K.W., Potter M. Activated neutrophils induce prolonged DNA damage in neighboring cells. Carcinogenesis. 9:1988;2297-2304.
21. Klein G. The approaching era of the tumor suppressor genes. Science. 238:1987;1539-1545.
22. Frenkel K., Khasak D., Karkoszka J., Shupack J., Stiller M. Enhanced antibody titers to an oxidized DNA base in inflammatory and neoplastic diseases. Exp. Dermatol. 1:1992;242-247.
23. Collins R.H. Jr, Feldman M., Fordtran J.S. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N. Engl. J. Med. 316:1987;1654-1658.
24. Mossman B.T., Bignon J., Corn M., Seaton A., Gee J.B. Asbestos scientific developments and implications for public policy . Science. 247:1990;294-301.
25. Muller H.J. Artificial transmutation of the gene. Science. 66:1927;84-87.
26. Cerutti P.A. DNA base damage induced by ionizing radiation. Wang S.Y., Photochemistry and photobiology of nucleic acids. 1976;375-401 Academic Press, New York.
27. Shellabarger C.J. Radiation carcinogenesis laboratory studies . Cancer. 37:1976;1090-1096.
28. Tokunaga M., Norman J.E. Jr, Asano M., Tokuoka S., Ezaki H., Nishimori I., Tsuji Y. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74. J. Natl. Cancer Inst. 62:1979;1347-1359.
29. Hutchinson F. Chemical changes induced in DNA by ionizing radiation. Prog. Nucleic Acid Res. Mol. Biol. 32:1985;115-154.
30. Goodhead D.T. The initial physical damage produced by ionizing radiations. Int. J. Radiat. Biol. 56:1989;623-634.
31. Goodhead D.T. Initial events in the cellular effects of ionizing radiations clustered damage in DNA . Int. J. Radiat. Biol. 65:1994;7-17.
32. Morgan W.F., Day J.P., Kaplan M.I., McGhee E.M., Limoli C.L. Genomic instability induced by ionizing radiation. Radiat. Res. 146:1996;247-258.
33. Adams G.E.D. Radiation carcinogenesis. Franks L.M., Teich N., Introduction to the cellular and molecular biology of cancer. 1986;154-175 Oxford University Press, New York.
34. Riley P.A. Free radicals in biology oxidative stress and the effects of ionizing radiation . Int. J. Radiat. Biol. 65:1994;27-33.
35. Halliwell B., Gutteridge J.M. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219:1984;1-14.
36. Forman, H. J.; Boveris, A. Superoxide radical and hydrogen peroxide in mitochondria. In: Pryor, W. A., ed. Free Radicals in Biology, vol. V. New York: Academic Press; 1982:65-90.
37. 2 in a thyroid particulate fraction requires Ca2+. FEBS Lett. 186:1985;107-110.
38. Imlay J.A., Chin S.M., Linn S. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science. 240:1988;640-642.
39. Dizdaroglu M., Rao G., Halliwell B., Gajewski E. Damage to the DNA bases in mammalian chromatin by hydrogen peroxide in the presence of ferric and cupric ions. Arch. Biochem. Biophys. 285:1991;317-324.
40. Skulachev V.P. Aging is a specific biological function rather than the result of a disorder in complex living systems biochemical evidence in support of Weismann's hypothesis . Biochemistry. 62:1997;1191-1195.
41. Michalik V., Maurizot M.S., Charlier M. Calculation of hydroxyl radical attack on different forms of DNA. J. Biomol. Struct. Dyn. 13:1995;565-575.
42. Blakely W.F., Fuciarelli A.F., Wegher B.J., Dizdaroglu M. Hydrogen peroxide-induced base damage in deoxyribonucleic acid. Radiat. Res. 121:1990;338-343.
43. Jackson J.H. Potential molecular mechanisms of oxidant-induced carcinogenesis. Environ. Health Perspect. 102:(Suppl. 10):1994;155-157.
44. Mello-Filho A.C., Meneghini R. In vivo formation of single-strand breaks in DNA by hydrogen peroxide is mediated by the Haber-Weiss reaction. Biochim. Biophys. Acta. 781:1984;56-63.
45. Moran, L. A.; Scrimgeour, K. G.; Horton, H. R.; Ochs, R. S.; Rawn, J. D. In: Biochemistry (2nd ed.). Upper Saddle River, NJ: Prentice Hall; 1994;18·24-18·25.
46. Parkes T.L., Elia A.J., Dickinson D., Hilliker A.J., Phillips J.P., Boulianne G.L. Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons. Nature Genet. 19:1998;171-174.
47. Orr W.C., Sohal R.S. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science. 263:1994;1128-1130.
48. Nathan C., Xie Q.W. Nitric oxide synthases roles, tolls, and controls . Cell. 78:1994;915-918.
49. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite implications for endothelial injury from nitric oxide and superoxide . Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
50. Cui S., Reichner J.S., Mateo R.B., Albina J.E. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res. 54:1994;2462-2467.
51. deRojas-Walker T., Tamir S., Ji H., Wishnok J.S., Tannenbaum S.R. Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. Chem. Res. Toxicol. 8:1995;473-477.
52. Magner L.N. A history of medicine. 1992;Marcel Dekker, Inc, New York.
53. Ford J.B. The earliest views. Sci. Am. 278:(4):1998;50-53.
54. Howard A., Pelc S.R. Synthesis of deoxyribonucleic acid in normal and irradiated cells and its relation to chromosome breakage. Heredity. 6:1953;261-273.
55. Baserga R. The biology of cell reproduction. 1985;Harvard University Press, Cambridge, MA.
56. Murray A., Hunt T. The cell cycle an introduction . 1993;W. H. Freeman and Co, New York.
57. Johnson R.T., Rao P.N. Mammalian cell fusion induction of premature chromosome condensation in interphase nuclei . Nature. 226:1970;717-722.
58. Rao P.N., Johnson R.T. Mammalian cell fusion studies on the regulation of DNA synthesis and mitosis . Nature. 225:1970;159-164.
59. Kaufmann W.K., Paules R.S. DNA damage and cell cycle checkpoints. FASEB J. 10:1996;238-247.
60. Hartwell L.H., Weinert T.A. Checkpoints controls that ensure the order of cell cycle events . Science. 246:1989;629-633.
61. Kastan, M. B., ed. Checkpoint controls and cancer. Tooze, J., ed. Cancer Surveys (vol. 29). Plainview, NY: Cold Spring Harbor Laboratory Press; 1997.
62. Nigg E.A. Cyclin-dependent protein kinases key regulators of the eukaryotic cell cycle . Bioessays. 17:1995;471-480.
63. Morgan D.O. Principles of CDK regulation. Nature. 374:1995;131-134.
64. Iliakis G. Cell cycle regulation in irradiated and nonirradiated cells. Semin. Oncol. 24:1997;602-615.
65. 1 phase of the cell cycle. Cell. 65:1991;701-713.
66. Pardee A.B., Dubrow R., Hamlin J.L., Kletzien R.F. Animal cell cycle. Ann. Rev. Biochem. 47:1978;715-750.
67. Levine A.J., Momand J., Finlay C.A. The p53 tumour suppressor gene. Nature. 351:1991;453-456.
68. 1. Cold Spring Harbor Symp. Quant. Biol. 56:1991;69-74.
69. Cocks B.G., Vairo G., Bodrug S.E., Hamilton J.A. Suppression of growth factor-induced CYL1 cyclin gene expression by antiproliferative agents. J. Biol. Chem. 267:1992;12307-12310.
70. Won K.-A., Xiong Y., Beach D., Gilman M.Z. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc. Natl. Acad. Sci. USA. 89:1992;9910-9914.
71. 1 phase in primary human T lymphocytes. J. Biol. Chem. 268:1993;4113-4119.
72. Matsushime H., Quelle D.E., Shurtleff S.A., Shibuya M., Sherr C.J., Kato J.Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:1994;2066-2076.
73. 1. Genes Dev. 7:1993;812-821.
74. 1 phase in rodent fibroblasts. Genes Dev. 7:1993;1559-1571.
75. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1994;1669-1679.
76. Motokura T., Bloom T., Kim H.G., Juppner H., Ruderman J.V., Kronenberg H.M., Arnold A. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 350:1991;512-515.
77. Seto M., Yamamoto K., Lida S., Akao Y., Utsumi K.R., Kubonishi I., Miyoshi I., Ohtsuki T., Yawata Y., Namba M., Motokura T., Arnold A., Takahashi T., Ueda R. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)-(q13;q32) translocation. Oncogene. 7:1992;1401-1406.
78. Lammie G.A., Fantl V., Smith R., Schuuring E., Brookes S., Michalides R., Dickson C., Arnold A., Peters G. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene. 6:1991;439-444.
79. 1 phase progression cycling on cue . Cell. 79:1994;551-555.
80. Kiyokawa H., Busquets X., Powell C.T., Ngo L., Rifkind R.A., Marks P.A. Cloning of a D-type cyclin from murine erythroleukemia cells. Proc. Natl. Acad. Sci. USA. 89:1992;2444-2447.
81. Motokura T., Keyomarsi K., Kronenberg H.M., Arnold A. Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. J. Biol. Chem. 267:1992;20412-20415.
82. Fantl V., Stamp G., Andrews A., Rosewell I., Dickson C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9:1995;2364-2372.
83. Sicinski P., Donaher J.L., Geng Y., Parker S.B., Gardner H., Park M.Y., Robker R.L., Richards J.S., McGinnis L.K., Biggers J.D., Eppig J.J., Bronson R.T., Elledge S.J., Weinberg R.A. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature. 384:1996;470-474.
84. Peters G. The D-type cyclins and their role in tumorigenesis. J. Cell Sci. 18:(Suppl.):1994;89-96.
85. 1 cyclins. Cell. 71:1992;323-334.
86. 1 kinase activity for Cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:1994;2077-2086.
87. Xiong Y., Zhang H., Beach D. D-type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell. 71:1992;505-514.
88. Khatib Z.A., Matsushime H., Valentine M., Shapiro D.N., Sherr C.J., Look A.T. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res. 53:1993;5535-5541.
89. Hunter T., Pines J. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell. 79:1994;573-582.
90. Schmidt E.E., Ichimura K., Reifenberger G., Collins V.P. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res. 54:1994;6321-6324.
91. 1 progression . Oncogene. 9:1994;2663-2674.
92. 1. J. Cell Biol. 125:1994;625-638.
93. Herwig S., Strauss M. The retinoblastoma protein a master regulator of cell cycle, differentiation and apoptosis . Eur. J. Biochem. 246:1997;581-601.
94. Nevins J.R. E2F a link between the Rb tumor suppressor protein and viral oncoproteins . Science. 258:1992;424-429.
95. 1/S phase. Proc. Natl. Acad. Sci. USA. 88:1991;1157-1161.
96. Pearson B.E., Nasheuer H.P., Wang T.S. Human DNA polymerase α gene sequences controlling expression in cycling and serum-stimulated cells . Mol. Cell. Biol. 11:1991;2081-2095.
97. 1/S-regulated E2F-containing protein complexes bind to the mouse thymidine kinase gene promoter. J. Biol. Chem. 269:1994;1306-1313.
98. Furukawa Y., Terui Y., Sakoe K., Ohta M., Saito M. The role of cellular transcription factor E2F in the regulation of Cdc2 mRNA expression and cell cycle control of human hematopoietic cells. J. Biol. Chem. 269:1994;26249-26258.
99. Johnson D.G., Ohtani K., Nevins J.R. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev. 8:1994;1514-1525.
100. Lee H.H., Chiang W.H., Chiang S.H., Liu Y.C., Hwang J., Ng S.Y. Regulation of cyclin D1, DNA topoisomerase I, and proliferating cell nuclear antigen promoters during the cell cycle. Gene Expr. 4:1995;95-109.
101. Ohtani K., DeGregori J., Nevins J.R. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA. 92:1995;12146-12150.
102. Schulze A., Zerfass K., Spitkovsky D., Middendorp S., Berges J., Helin K., Jansen-Durr P., Henglein B. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc. Natl. Acad. Sci. USA. 92:1995;11264-11268.
103. Tommasi S., Pfeifer G.P. in vivo structure of the human Cdc2 promoter release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of Cdc2 expression . Mol. Cell. Biol. 15:1995;6901-6913.
104. Botz J., Zerfass-Thome K., Spitkovsky D., Delius H., Vogt B., Eilers M., Hatzigeorgiou A., Jansen-Durr P. Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol. Cell. Biol. 16:1996;3401-3409.
105. Geng Y., Eaton E.N., Picon M., Roberts J.M., Lundberg A.S., Gifford A., Sardet C., Weinberg R.A. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene. 12:1996;1173-1180.
106. Oswald F., Dobner T., Lipp M. The E2F transcription factor activates a replication-dependent human H2A gene in early S phase of the cell cycle. Mol. Cell. Biol. 16:1996;1889-1895.
107. Slansky J.E., Farnham P.J. Transcriptional regulation of the dihydrofolate reductase gene. Bioessays. 18:1996;55-62.
108. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 12:1998;2245-2262.
109. Koff A., Cross F., Fisher A., Schumacher J., Leguellec K., Philippe M., Roberts J.M. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell. 66:1991;1217-1228.
110. 1 cyclin (Cln) function in yeast. Cell. 66:1991;1197-1206.
111. 1 phase of the human cell cycle. Science. 257:1992;1689-1694.
112. 1-S phase protein kinase. Science. 257:1992;1958-1961.
113. 1-to-S phase transition. Mol. Cell. Biol. 15:1995;2612-2624.
114. Lundberg A.S., Weinberg R.A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-Cdk complexes. Mol. Cell. Biol. 18:1998;753-761.
115. Kip1. Mol. Cell. Biol. 15:1995;4347-4352.
116. Minshull J., Golsteyn R., Hill C.S., Hunt T. The A- and B-type cyclin associated Cdc2 kinases in Xenopus turn on and off at different times in the cell cycle. EMBO J. 9:1990;2865-2875.
117. Pines J., Hunter T. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature. 346:1990;760-763.
118. Girard F., Strausfeld U., Fernandez A., Lamb N.J. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell. 67:1991;1169-1179.
119. Lehner C.F., O'Farrell P.H. The roles of Drosophila cyclins A and B in mitotic control. Cell. 61:1990;535-547.
120. 2 phases of the cell cycle and associates with cyclin A. Proc. Natl. Acad. Sci. USA. 89:1992;2824-2828.
121. 2 phase mutant with a temperature-sensitive CDC2 gene product. Cell. 63:1990;313-324.
122. 2-M transitions are controlled by different Cdc2 proteins in higher eukaryotes. Cell. 66:1991;731-742.
123. Pagano M., Pepperkok R., Verde F., Ansorge W., Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J. 11:1992;961-971.
124. Peeper D.S., Parker L.L., Ewen M.E., Toebes M., Hall F.L., Xu M., Zantema A., Van der Eb A.J., Piwnica-Worms H. A-type and B-type cyclins differentially modulate substrate specificity of cyclin-Cdk complexes. EMBO J. 12:1993;1947-1954.
125. 1/S transition and S-phase progression . Genes Dev. 12:1998;2278-2292.
126. Chao Y., Shih Y.L., Chiu J.H., Chau G.Y., Lui W.Y., Yang W.K., Lee S.D., Huang T.S. Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res. 58:1998;985-990.
127. Jiang W., Hunter T. Identification and characterization of a human protein kinase related to budding yeast Cdc7p. Proc. Natl. Acad. Sci. USA. 94:1997;14320-14325.
128. Tanaka T., Knapp D., Nasmyth K. Loading of an Mcm protein onto DNA replication origins is regulated by Cdc6p and CDKs. Cell. 90:1997;649-660.
129. Jiang W., Wells N.J., Hunter T. Multistep regulation of DNA replication by Cdk phosphorylation of HsCdc6. Proc. Natl. Acad. Sci. USA. 96:1999;6193-6198.
130. Jiang W., McDonald D., Hope T.J., Hunter T. Mammalian Cdc7-Dbf4 protein kinase complex is essential for initiation of DNA replication. EMBO J. 18:1999;5703-5713.
131. 1/S transition in mammalian cells. Mol. Cell. Biol. 19:1999;5083-5095.
132. cdc2 . Cell. 58:1989;833-846.
133. Arion D., Meijer L., Brizuela L., Beach D. Cdc2 is a component of the M phase-specific histone H1 kinase evidence for identity with MPF . Cell. 55:1988;371-378.
134. Dunphy W.G., Brizuela L., Beach D., Newport J. The Xenopus Cdc2 protein is a component of MPF, a cytoplasmic regulator of mitosis. Cell. 54:1988;423-431.
135. Gautier J., Norbury C., Lohka M., Nurse P., Maller J. Purified maturation-promoting factor contains the product of a Xenopus homolog of the fission yeast cell cycle control gene Cdc2+. Cell. 54:1988;433-439.
136. Lee M., Nurse P. Cell cycle control genes in fission yeast and mammalian cells. Trends Genet. 4:1988;287-290.
137. Lohka M.J., Hayes M.K., Maller J.L. Purification of maturation-promoting factor, an intracellular regulator of early mitotic events. Proc. Natl. Acad. Sci. USA. 85:1988;3009-3013.
138. Labbe J.C., Capony J.P., Caput D., Cavadore J.C., Derancourt J., Kaghad M., Lelias J.M., Picard A., Doree M. MPF from starfish oocytes at first meiotic metaphase is a heterodimer containing one molecule of Cdc2 and one molecule of cyclin B. EMBO J. 8:1989;3053-3058.
139. Gautier J., Minshull J., Lohka M., Glotzer M., Hunt T., Maller J.L. Cyclin is a component of maturation-promoting factor from Xenopus. Cell. 60:1990;487-494.
140. Pines J., Hunter T. Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J. Cell Biol. 115:1991;1-17.
141. Gallant P., Nigg E.A. Cyclin B2 undergoes cell cycle-dependent nuclear translocation and, when expressed as a non-destructible mutant, causes mitotic arrest in HeLa cells. J. Cell Biol. 117:1992;213-224.
142. cdc2-cyclin B complex at meiosis reinitiation in starfish oocytes. EMBO J. 11:1992;1763-1772.
143. Gallant P., Nigg E.A. Identification of a novel vertebrate cyclin cyclin-B3 shares properties with both A- and B-type cyclins . EMBO J. 13:1994;595-605.
144. Pines J., Hunter T. The differential localization of human cyclins A and B is due to a cytoplasmic retention signal in cyclin B. EMBO J. 13:1994;3772-3781.
145. Jackman M., Firth M., Pines J. Human cyclins B1 and B2 are localized to strikingly different structures B1 to microtubules, B2 primarily to the Golgi apparatus . EMBO J. 14:1995;1646-1654.
146. Li J., Meyer A.N., Donoghue D.J. Nuclear localization of cyclin B1 mediates its biological activity and is regulated by phosphorylation. Proc. Natl. Acad. Sci. USA. 94:1997;502-507.
147. cdc2 protein kinase component of purified maturation-promoting factor from Xenopus eggs. J. Biol. Chem. 264:1989;19577-19582.
148. Brandeis M., Rosewell I., Carrington M., Crompton T., Jacobs M.A., Kirk J., Gannon J., Hunt T. Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero. Proc. Natl. Acad. Sci. USA. 95:1998;4344-4349.
149. Draetta G. Cell cycle control in eukaryotes molecular mechanisms of Cdc2 activation . Trends Biochem. Sci. 15:1990;378-383.
150. Norbury C., Nurse P. Animal cell cycles and their control. Annu. Rev. Biochem. 61:1993;441-470.
151. 1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
152. Morgan D.O. Cyclin-dependent kinases engines, clocks, and microprocessors . Annu. Rev. Cell Dev. Biol. 13:1997;261-291.
153. Nigg E.A. Cyclin-dependent kinase 7 at the cross-roads of transcription, DNA repair and cell cycle control? Curr. Opin. Cell Biol. 8:1996;312-317.
154. Draetta G.F. Cell cycle will the real Cdk-activating kinase please stand up . Curr. Biol. 7:1997;50-52.
155. Lundgren K., Walworth N., Booher R., Dembski M., Kirschner M., Beach D. Mik1 and Wee1 cooperate in the inhibitory tyrosine phosphorylation of Cdc2. Cell. 64:1991;1111-1122.
156. cdc2 in a Wee1+ dependent manner. EMBO J. 10:1991;1255-1263.
157. Booher R.N., Holman P.S., Fattaey A. Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity. J. Biol. Chem. 272:1997;22300-22306.
158. Gould K.L., Nurse P. Tyrosine phosphorylation of the fission yeast Cdc2+ protein kinase regulates entry into mitosis. Nature. 342:1989;39-45.
159. cdc2 regulation. Mol. Cell. Biol. 13:1993;1675-1685.
160. cdc2. Cell. 67:1991;197-211.
161. Kumagai A., Dunphy W.G. The Cdc25 protein controls tyrosine dephosphorylation of the Cdc2 protein in a cell-free system. Cell. 64:1991;903-914.
162. cdc2/cyclin B complex in vitro by human CDC25 protein. Nature. 351:1991;242-245.
163. Kumagai A., Dunphy W.G. Regulation of the Cdc25 protein during the cell cycle in Xenopus extracts. Cell. 70:1992;139-151.
164. Hoffmann I., Clarke P.R., Marcote M.J., Karsenti E., Draetta G. Phosphorylation and activation of human Cdc25-C by Cdc2/cyclin-B and its involvement in the self-amplification of MPF at mitosis. EMBO J. 12:1993;53-63.
165. Elledge S.J. Cell cycle checkpoints preventing an identity crisis . Science. 274:1996;1664-1672.
166. 1 arrest. Proc. Natl. Acad. Sci. USA. 93:1996;4827-4832.
167. Little J.B. Delayed initiation of DNA synthesis in irradiated human diploid cells. Nature. 218:1968;1064-1065.
168. Kastan M.B., Onyekere O., Sidransky D., Volgelstein B., Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
169. Maltzman W., Czyzyk L. UV irradiation stimulates levels of p53 cellular tumour antigen in nontransformed mouse cells. Mol. Cell. Biol. 4:1984;1689-1694.
170. Campbell C., Quinn A.G., Angus B., Farr P.M., Rees J.L. Wavelength specific patterns of p53 induction in human skin following exposure to UV radiation. Cancer Res. 53:1993;2697-2699.
171. Nelson W.G., Kastan M.B. DNA strand breaks the DNA template alterations that trigger p53-dependent DNA damage response pathways . Mol. Cell. Biol. 14:1994;1815-1823.
172. 2 checkpoint function in human fibroblasts. Submitted; 2000.
173. 1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8:1994;2540-2551.
174. 1/S cell cycle checkpoint defect in ataxia-telangiectasia. Oncogene. 11:1995;609-618.
175. Kern S.E., Kinzler K.W., Bruskin A., Jarosz D., Friedman P., Prives C., Vogelstein B. Identification of p53 as a sequence-specific DNA-binding protein. Science. 252:1991;1708-1711.
176. Funk W.D., Pak D.T., Karas R.H., Wright W.E., Shay J.W. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol. 12:1992;2866-2871.
177. Kastan, M. B.; Zhan, Q.; El-Deiry, W. S.; Carrier, F.; Jacks, T.; Walsh, W. V.; Plunkett, B. S.; Vogelstein, B.; Fornace, A. J. J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597; 1992.
178. 1 arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
179. Ragimov N., Krauskopf A., Navot N., Rotter V., Oren M., Aloni Y. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif. Oncogene. 8:1993;1183-1193.
180. Jiang H., Lin J., Su Z.Z., Collart F.R., Huberman E., Fisher P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene. 9:1994;3397-3406.
181. Michieli P., Chedid M., Lin D., Pierce J.H., Mercer W.E., Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54:1994;3391-3395.
182. Macleod K.F., Sherry N., Hannon G., Beach D., Tokino T., Kinzler K., Vogelstein B., Jacks T. p53-Dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9:1995;935-944.
183. WAF1/CIP1 expression in pericentral hepatocytes following carbon tetrachloride intoxication. Cell Growth Differ. 8:1997;951-961.
184. 1 cyclin-dependent kinases. Cell. 75:1993;805-816.
185. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
186. Zhang H., Hannon G.J., Beach D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1994;1750-1758.
187. 1 arrest. Cell. 76:1994;1013-1023.
188. Harper J.W., Elledge S.J., Keyomarsi K., Dynlacht B., Tsai L.H., Zhang P.M., Dobrowolski S., Bai C., Connellcrowley L., Swindell E., Fox M.P., Wei N. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell. 6:1995;387-400.
189. 2/M-phase transition . Mol. Cell. Biol. 18:1998;546-557.
190. 1 checkpoint control. Cell. 82:1995;675-684.
191. 1 cyclin-Cdk protein kinase activity, is related to p21. Cell. 78:1994;67-74.
192. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:1995;650-662.
193. Gu Y., Rosenblatt J., Morgan D.O. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11:1992;3995-4005.
194. Sebastian B., Kakizuka A., Hunter T. Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc. Natl. Acad. Sci. USA. 90:1993;3521-3524.
195. 0-like arrest. Mol. Cell. Biol. 16:1996;3934-3944.
196. Jinno S., Suto K., Nagata A., Igarashi M., Kanaoka Y., Nojima H., Okayama H. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J. 13:1994;1549-1556.
197. 1 arrest induced by ultraviolet irradiation. Nature. 376:1995;358-362.
198. Serrano M., Hannon G.J., Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin-D/CDK4. Nature. 366:1993;704-707.
199. Lukas J., Parry D., Aagaard L., Mann D.J., Bartkova J., Strauss M., Peters G., Bartek J. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature. 375:1995;503-506.
200. Serrano M., Lee H., Chin L., Cordon-Cardo C., Beach D., DePinho R.A. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 85:1996;27-37.
201. Otterson G.A., Khleif S.N., Chen W., Coxon A.B., Kaye F.J. CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2′deoxycytidine. Oncogene. 11:1995;1211-1216.
202. Ichikawa Y., Yoshida S., Koyama Y., Hirai M., Ishikawa T., Nishida M., Tsunoda H., Kubo T., Miwa M., Uchida K. Inactivation of p16/CDKN2 and p15/MTS2 genes in different histological types and clinical stages of primary ovarian tumors. Int. J. Cancer. 69:1996;466-470.
203. Lo K.W., Cheung S.T., Leung S.F., van-Hasselt A., Tsang Y.S., Mak K.F., Chung Y.F., Woo J.K., Lee J.C., Huang D.P. Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res. 56:1996;2721-2725.
204. Foulkes W.D., Flanders T.Y., Pollock P.M., Hayward N.K. The CDKN2A (p16) gene and human cancer. Mol. Med. 3:1997;5-20.
205. ARF. Cell. 91:1997;649-659.
206. Quelle D.E., Zindy F., Ashmun R.A., Sherr C.J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 83:1995;993-1000.
207. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell. 92:1998;713-723.
208. Makino F., Okada S. Effects of ionizing radiation on DNA replication in cultured mammalian cells. Radiat. Res. 62:1975;37-51.
209. Painter R.B., Young B.R. X-ray-induced inhibition of DNA synthesis in Chinese hamster ovary, human HeLa, and mouse L cells. Radiat. Res. 64:1975;648-656.
210. Painter R.B., Young B.R. Formation of nascent DNA molecules during inhibition of replicon initiation in mammalian cells. Biochim. Biophys. Acta. 418:1976;146-153.
211. Painter R.B., Young B.R. Radiosensitivity in ataxia-telangiectasia a new explanation . Proc. Natl. Acad. Sci. USA. 77:1980;7315-7317.
212. Larner J.M., Lee H., Hamlin J.L. Radiation effects on DNA synthesis in a defined chromosomal replicon. Mol. Cell. Biol. 14:1994;1901-1908.
213. Cleaver J.E., Rose R., Mitchell D.L. Replication of chromosomal and episomal DNA in X-ray-damaged human cells a cis- or trans-acting mechanism? Radiat. Res. 124:1990;294-299.
214. Cistulli C.A., Kaufmann W.K. p53-dependent signaling sustains DNA replication and enhances clonogenic survival in 254 nm ultraviolet-irradiated human fibroblasts. Cancer Res. 58:1998;1993-2002.
215. Beamish H., Williams R., Chen P., Lavin M.F. Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation. J. Biol. Chem. 271:1996;20486-20493.
216. 2 arrest in Chinese hamster ovary cells. Cancer Res. 50:1990;3761-3766.
217. cdc2 kinase in etoposide-induced cell death of Chinese hamster ovary cells. Cancer Res. 50:1990;3767-3771.
218. 2 checkpoint function precedes human cell immortalization. Cancer Res. 55:1995;7-11.
219. 2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res. 55:1995;1763-1773.
220. Herzinger T., Funk J.O., Hillmer K., Eick D., Wolf D.A., Kind P. Ultraviolet B irradiation-induced G2 cell cycle arrest in human keratinocytes by inhibitory phosphorylation of the Cdc2 cell cycle kinase. Oncogene. 11:1995;2151-2156.
221. 2 arrest in human cells. J. Cell Biol. 134:1996;963-970.
222. 2 arrest induced by nitrogen mustard. Proc. Natl. Acad. Sci. USA. 91:1994;9480-9484.
223. 2 checkpoint control regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216 . Science. 277:1997;1501-1505.
224. Sanchez Y., Wong C., Thoma R.S., Richman R., Wu R.Q., Piwnica-Worms H., Elledge S.J. Conservation of the Chk1 checkpoint pathway in mammals linkage of DNA damage to Cdk regulation through Cdc25 . Science. 277:1997;1497-1501.
225. Matsuoka S., Huang M.X., Elledge S.J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science. 282:1998;1893-1897.
226. Brown A.L., Lee C.H., Schwarz J.K., Mitiku N., Piwnica-Worms H., Chung J.H. A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc. Natl. Acad. Sci. USA. 96:1999;3745-3750.
227. Weinert T. Cell cyclea DNA damage checkpoint meets the cell cycle engine. Science. 277:1997;1450-1451.
228. Zampetti-Bosseler F., Scott D. Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after X-irradiation. Int. J. Radiat. Biol. 39:1981;547-558.
229. Scott D., Zampetti-Bosseler F. Cell cycle dependence of mitotic delay in X-irradiated normal and ataxia telangiectasia fibroblasts. Int. J. Radiat. Biol. 42:1982;679-683.
230. Beamish H., Lavin M.F. Radiosensitivity in ataxia-telangiectasia anomalies in radiation-induced cell cycle delay . Int. J. Radiat. Biol. 65:1994;175-184.
231. Nagasawa H., Latt S.A., Lalande M.E., Little J.B. Effects of X-irradiation on cell cycle progression, induction of chromosomal aberrations and cell killing in ataxia telangiectasia (AT) fibroblasts. Mutat. Res. 148:1985;71-82.
232. 2 blocks, cyclin B expression and Cdc2 expression in human squamous carcinoma cell lines with different radiosensitivities. Radiother. Oncol. 33:1994;217-227.
233. Jin P., Hardy S., Morgan D.O. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J. Cell Biol. 141:1998;875-885.
234. 2 checkpoint. EMBO J. 17:1998;2728-2735.
235. Chan T.A., Hermeking H., Lengauer C., Kinzler K.W., Vogelstein B. 14-3-3s is required to prevent mitotic catastrophe after DNA damage. Nature. 401:1999;616-620.
236. 2 block induced by ionizing radiation. Cancer Res. 51:1991;5113-5117.
237. Muschel R.J., Zhang H.B., McKenna W.G. Differential effect of ionizing radiation on the expression of cyclin A and cyclin B in HeLa cells. Cancer Res. 53:1993;1128-1135.
238. Maity A., Mckenna W.G., Muschel R.J. Evidence for post-transcriptional regulation of cyclin B1 mRNA in the cell cycle and following irradiation in HeLa cells. EMBO J. 14:1995;603-609.
239. 2 delay induced by nitrogen mustard in human cells affects cyclin A/Cdk2 and cyclin B1/Cdc2-kinase complexes differently. J. Biol. Chem. 268:1993;8298-8308.
240. Barth H., Hoffmann I., Kinzel V. Radiation with 1 Gy prevents the activation of the mitotic inducers mitosis-promoting factor (MPF) and Cdc25-C in HeLa cells. Cancer Res. 56:1996;2268-2272.
241. Poon R.Y.C., Jiang W., Toyoshima H., Hunter T. Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage. J. Biol. Chem. 271:1996;13283-13291.
242. Poon R.Y.C., Chau M.S., Yamashita K., Hunter T. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res. 57:1997;5168-5178.
243. Rice R.H., Steinmann K.E., deGraffenried L.A., Qin Q., Taylor N., Schlegel R. Elevation of cell cycle control proteins during spontaneous immortalization of human keratinocytes. Mol. Biol. Cell. 4:1993;185-194.
244. Steinmann K.E., Pei X.F., Stoppler H., Schlegel R., Schlegel R. Elevated expression and activity of mitotic regulatory proteins in human papillomavirus immortalized keratinocytes. Oncogene. 9:1994;387-394.
245. 2 checkpoint function and chromosomal destabilization are linked in human fibroblasts expressing human papillomavirus type 16 E6. Cell Growth Differ. 8:1997;1105-1114.
246. Chang T.H.T., Ray F.A., Thompson D.A., Schlegel R. Disregulation of mitotic checkpoints and regulatory proteins following acute expression of SV40 large T antigen in diploid human cells. Oncogene. 14:1997;2383-2393.
247. Walters R.A., Gurley L.R., Tobey R.A. Effects of caffeine on radiation-induced phenomena associated with cell-cycle traverse of mammalian cells. Biophys. J. 14:1974;99-118.
248. Snyder, M. H.; Kimler, B. F.; Leeper, D. B. The effect of caffeine on radiation-induced division delay. Int. J. Radiat. Biol. 32:281-284; 1977.
249. Tolmach L.J., Jones R.W., Busse P.M. The action of caffeine on X-irradiated HeLa cells. I. Delayed inhibition of DNA synthesis. Radiat. Res. 71:1977;653-665.
250. 2 delay. Radiat. Res. 74:1978;112-128.
251. Lau C.C., Pardee A.B. Mechanism by which caffeine potentiates lethality of nitrogen mustard. Proc. Natl. Acad. Sci. USA. 79:1982;2942-2946.
252. Schlegel R., Pardee A.B. Caffeine-induced uncoupling of mitosis from the completion of DNA replication in mammalian cells. Science. 232:1986;1264-1266.
253. 2 arrest by caffeine. Radiat. Res. 129:1992;224-227.
254. 2-phase cell cycle blocks are equally released by caffeine. Radiat. Res. 135:1993;372-379.
255. Fingert H.J., Chang J.D., Pardee A.B. Cytotoxic, cell cycle, and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agents. Cancer Res. 46:1986;2463-2467.
256. Musk S.R., Steel G.G. Override of the radiation-induced mitotic block in human tumour cells by methylxanthines and its relationship to the potentiation of cytotoxicity. Int. J. Radiat. Biol. 57:1990;1105-1112.
257. Teicher B.A., Holden S.A., Herman T.S., Epelbaum R., Pardee A.B., Dezube B. Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo. Anticancer Res. 11:1991;1555-1560.
258. 2 delay. Cancer Res. 55:1995;1643-1648.
259. 1 checkpoint-competent cells. Cancer Res. 55:1995;1639-1642.
260. Shiloh Y., Tabor E., Becker Y. Colony-forming ability of ataxia-telangiectasia skin fibroblasts is an indicator of their early senescence and increased demand for growth factors. Exp. Cell Res. 140:1982;191-199.
261. McKinnon P.J. Ataxia-telangiectasia an inherited disorder of ionizing-radiation sensitivity in man . Hum. Genet. 75:1987;197-208.
262. Vuillaume M. Reduced oxygen species, mutation, induction and cancer initiation. Mutat. Res. 186:1987;43-72.
263. Gatti R.A. Localizing the genes for ataxia-telangiectasia a human model for inherited cancer susceptibility . Adv. Cancer Res. 56:1991;77-104.
264. 2 delay and spontaneous chromosome aberrations in ataxia-telangiectasia homozygotes and heterozygotes. Int. J. Radiat. Biol. 66:S157-S163; 1994.
265. Ward A.J., Olive P.L., Burr A.H., Rosin M.P. Response of fibroblast cultures from ataxia-telangiectasia patients to reactive oxygen species generated during inflammatory reactions. Environ. Mol. Mutagen. 24:1994;103-111.
266. Green M.H.L., Marcovitch A.J., Harcourt S.A., Lowe J.E., Green I.C., Arlett C.F. Hypersensitivity of ataxia-telangiectasia fibroblasts to a nitric oxide donor. Free Radic. Biol. Med. 22:1997;343-347.
267. Taylor A.M. Unrepaired DNA strand breaks in irradiated ataxia telangiectasia lymphocytes suggested from cytogenetic observations. Mutat. Res. 50:1978;407-418.
268. Dettmer C.M., Kramer S., Gottlieb S.F., Aponte G.E. Carcinogenic properties of increased oxygen tensions. I. Effects on radiation-induced mammary tumors. J. Natl. Cancer Inst. 41:1968;751-756.
269. Bruyninckx W.J., Mason H.S., Morse S.A. Are physiological oxygen concentrations mutagenic? Nature. 274:1978;606-607.
270. Sturrock J.E., Nunn J.F. Chromosomal damage and mutations after exposure of Chinese hamster cells to high concentrations of oxygen. Mutat. Res. 57:1978;27-33.
271. Moody C.S., Hassan H.M. Mutagenicity of oxygen free radicals. Proc. Natl. Acad. Sci. USA. 79:1982;2855-2859.
272. Newcomb T.G., Loeb L.A. Oxidative DNA damage and mutagenesis. Nickoloff J.A., Hoekstra M.F., DNA damage and repair, vol. I DNA repair in prokaryotes and lower eukaryotes . 1998;65-84 Humana Press Inc, Totowa, NJ.
273. Clopton D.A., Saltman P. Low-level oxidative stress causes cell-cycle specific arrest in cultured cells. Biochem. Biophys. Res. Commun. 210:1995;189-196.
274. 1 arrest independent of RAD function. J. Biol. Chem. 273:1998;8564-8571.
275. Russo T., Zambrano N., Esposito F., Ammendola R., Cimino F., Fiscella M., Jackman J., O'Connor P.M., Anderson C.W., Appella E. A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J. Biol. Chem. 270:1995;29386-29391.